Breviscapine dispersible tablets
Function and Efficacy
The results of non-clinical pharmacodynamic tests indicate that this product can reduce the wet weight and water content of the brain in rats with brain damage caused by local cerebral ischemia of the middle cerebral artery, reduce the scope of cerebral infarction, and significantly prolong the survival time of mice poisoned by sodium nitrite.
Ingredients
Breviscapine
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| BREVISCAPINIngredients |
It can reduce the brain wet weight and brain water content of rats with brain damage caused by local cerebral ischemia of the middle cerebral artery, reduce the scope of cerebral infarction, and significantly prolong the survival time of mice poisoned by sodium nitrite More |
116122-36-2 | 0 |
Appearance
This product is light yellow tablets with slight odor and light or slightly salty taste.
Usage and Dosage
Oral administration: 2 tablets at a time, 3 times a day.
Adverse Reactions
Not yet clear.
Precautions
It is contraindicated for those who are allergic to this product.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
Sealed and protected from light.
Packaging Specification
Each tablet contains 20 mg of breviscapine
Validity Period
24 months
Manufacturer
Shanxi Zhendong Pharmaceutical Co., Ltd.
-
Founded in:
1995-11-15 -
Address:
Zhendong Science and Technology Park, Guangming South Road, Shangdang District, Changzhi City, Shanxi Province -
Tax NO.:
91140400729655415C -
Registered Funds:
1,005,319,756 yuan -
Website:
-
Email: